Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Basel Medical Group Ltd (BMGL)

3.7500 +0.1500 (+4.17%)
At close: October 9 at 4:00:01 PM EDT
3.7000 -0.0500 (-1.33%)
After hours: October 9 at 7:42:00 PM EDT
Chart Range Bar
Loading chart for BMGL
  • Previous Close 3.6000
  • Open 3.5000
  • Bid 2.2500 x 200
  • Ask 3.9500 x 200
  • Day's Range 3.4400 - 3.8800
  • 52 Week Range 2.5600 - 21.7200
  • Volume 103,915
  • Avg. Volume 532,962
  • Market Cap (intraday) 5.933M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -4.9800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.

baselmedical.com

82

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BMGL
36.22%
S&P 500 (^GSPC)
14.11%

1-Year Return

BMGL
81.06%
S&P 500 (^GSPC)
15.98%

3-Year Return

BMGL
92.54%
S&P 500 (^GSPC)
80.17%

5-Year Return

BMGL
92.54%
S&P 500 (^GSPC)
77.89%

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    6.47M

  • Enterprise Value

    12.46M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    1.32

  • Enterprise Value/Revenue

    1.09

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -68.19%

  • Return on Assets (ttm)

    -15.46%

  • Return on Equity (ttm)

    -147.37%

  • Revenue (ttm)

    14.74M

  • Net Income Avi to Common (ttm)

    -10.05M

  • Diluted EPS (ttm)

    -4.9800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.45M

  • Total Debt/Equity (mrq)

    151.30%

  • Levered Free Cash Flow (ttm)

    -11.75M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.7500 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: